Mo Ling Chen

Ms. Mo Ling Chen is Partner at Edmond De Rothschild Investment Partners (Shanghai) Ltd. Ms. Chen was previously employed as Senior Principal by BioVeda Investment Consulting.
Ms. Mo Ling Chen, has over 10 years science, business and investment experience in the Biotechnology and Pharmaceutical industries in Asia and Australasia.
She was previously with BioVeda Capital Singapore and involved in the funding of biotech ventures in US, Europe, Singapore and China, where she facilitated the Asian expansion plan of BioVeda’s portfolio companies in the region.
She was also involved with start-up companies in fund-raising and corporate strategy such as Asia Natural Products.
Prior to joining BioVeda Capital Singapore, Ms. Chen was the Australasian Territory Manager with Chiron Mimotopes, a world leader in Combinatorial Chemistry based in Melbourne Australia.
During her tenure there, she grew the Company’s business in the region by more than 50%.
Ms. Chen started her career with the Institute of Drug Technology, Australia (ASX:IDT) as an Analytical Chemist.
Born in Beijing, Ms. Chen holds a MBA from Monash Mt Eliza Business School and a Bachelor degree in Chemistry from Royal Melbourne Institute of Technology University in Melbourne.